Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.60 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.60 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.60 |
| ▸ | CETP | P11597 | 1/20 | 0.54 |
| ▸ | GJB2 | P29033 | 1/20 | 0.52 |
| ▸ | GBA1 | P04062 | 1/20 | 0.51 |
| ▸ | IGF2R | P11717 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14673220 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL2969833 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL2446441 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL25480871 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL17366539 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL23016771 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL22691938 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL22111992 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL21067398 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP | |
| SCHEMBL2446731 | 1.00 | MAPK1 (0.65) | MAPK1LGALS8LGALS3LGALS4CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11433136-B2 | Polyacetal polymers, conjugates, particles and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2022-09-06 | — | — | US | disclosed |
| WO-2020201771-A1 | NEW PHARMACEUTICAL COMPOSITIONS | OREXO AB (SE) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020201768-A1 | PHARMACEUTICAL COMPOSITIONS | OREXO AB (SE) | 2020-10-08 | — | — | WO | disclosed |
| WO-2019064026-A1 | NEW PHARMACEUTICAL COMPOSITIONS | OREXO AB (SE) | 2019-04-04 | — | — | WO | disclosed |
| US-20180360978-A1 | POLYACETAL POLYMERS, CONJUGATES, PARTICLES AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2018-12-20 | — | — | US | disclosed |
| EP-3389720-A1 | POLYACETAL POLYMERS, CONJUGATES, PARTICLES AND USES THEREOF | The General Hospital Corporation (US) | 2018-10-24 | — | — | EP | disclosed |
| WO-2018106738-A1 | BRUSH-ARM STAR POLYMERS, CONJUGATES AND PARTICLES, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-06-14 | — | — | WO | disclosed |
| WO-2017106630-A1 | POLYACETAL POLYMERS, CONJUGATES, PARTICLES AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2017-06-22 | — | — | WO | disclosed |
| US-7566766-B2 | Peptides which enhance transport across tissues and methods of identifying and using the same | EUSA Pharma Ltd. (GB) | 2009-07-28 | — | — | US | disclosed |
| US-20060275746-A9 | Peptides which enhance transport across tissues and methods of identifying and using the same | O'MAHONY DANIEL J | 2006-12-07 | — | — | US | disclosed |
| US-6521737-B1 | Coded by bacteriophage from selected library; drug delivery | ELAN CORPORATION, PLC (IE) | 2003-02-18 | — | — | US | disclosed |
| EP-1281718-A2 | Peptides which enhance transport across tissues | ELAN CORPORATION, Plc (IE) | 2003-02-05 | — | — | EP | disclosed |
| US-6361938-B1 | ADMINISTERING IN SITU OR IN VITRO A KNOWN AMOUNT OF PHAGE FROM A RANDOM PHAGE LIBRARY INTO THE GASTRO-INTESTINE TRACT OF AN ANIMAL; AFTER A TIME PERIOD, PHAGE TRANSPORTED ACROSS A TISSUE BARRIER IS HARVESTED FROM BLOOD OR BRAIN TISSUE | ELAN CORPORATION, PLC (IR) | 2002-03-26 | — | — | US | disclosed |
| US-6117632-A | DETECTION OF PROTEIN SEQUENCES WHICH TRANSFER COMPOUNDS ACROSS HUMAN AND ANIMAL TISSUES; INCUBATION OF PHAGE WITH TISSUE, RECOVER TRANSPORTED PHAGE, AMPLIFY, REPEAT PROCESS WITH RECOVERED PHAGE, DETECT TRANSPORT PROTEIN SEQUENCES | ELAN CORPORATION, PLC (IE) | 2000-09-12 | — | — | US | disclosed |
| EP-0981649-A1 | PEPTIDES WHICH ENHANCE TRANSPORT OF AN ACTIVE AGENT ACROSS TISSUES AND COMPOSITIONS AND METHODS OF USING THE SAME | ELAN CORPORATION, Plc (IE) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998051825-A1 | PEPTIDES WHICH ENHANCE TRANSPORT OF AN ACTIVE AGENT ACROSS TISSUES AND COMPOSITIONS AND METHODS OF USING THE SAME | ELAN CORPORATION, PLC (IE) | 1998-11-19 | — | — | WO | disclosed |
| EP-0876615-A1 | PEPTIDES WHICH ENHANCE TRANSPORT ACROSS TISSUES AND METHODS OF IDENTIFYING AND USING THE SAME | ELAN CORPORATION PLC (IE) | 1998-11-11 | — | — | EP | disclosed |
| EP-0859959-A1 | PEPTIDES WHICH ENHANCE TRANSPORT ACROSS TISSUES AND METHODS OF IDENTIFYING AND USING THE SAME | ELAN CORPORATION, Plc (IE) | 1998-08-26 | — | — | EP | disclosed |
| WO-1997017613-A1 | PEPTIDES WHICH ENHANCE TRANSPORT ACROSS TISSUES AND METHODS OF IDENTIFYING AND USING THE SAME | ELAN CORPORATION, PLC (IE) | 1997-05-15 | — | — | WO | disclosed |
| WO-1997017614-A1 | PEPTIDES WHICH ENHANCE TRANSPORT ACROSS TISSUES AND METHODS OF IDENTIFYING AND USING THE SAME | ELAN CORPORATION, PLC (IE) | 1997-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180360978-A1 | POLYACETAL POLYMERS, CONJUGATES, PARTICLES AND USES THEREOF | CD44, FUT6, MSN | MAPK1 3621/4885LGALS8 347/4885LGALS3 128/4885 |
| US-11433136-B2 | Polyacetal polymers, conjugates, particles and uses thereof | CD44, FUT6, MSN | MAPK1 3621/4885LGALS8 347/4885LGALS3 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.